Jakob Dupont
2016 - OncoMed Pharmaceuticals
In 2016, Jakob Dupont earned a total compensation of $706.9K as Former Senior Vice President Chief Medical Officer at OncoMed Pharmaceuticals, a 52% decrease compared to previous year.
Compensation breakdown
| Non-Equity Incentive Plan | $149,555 |
|---|---|
| Salary | $415,553 |
| Stock Awards | $141,750 |
| Total | $706,858 |
Dupont received $415.6K in salary, accounting for 59% of the total pay in 2016.
Dupont also received $149.6K in non-equity incentive plan and $141.8K in stock awards.
Rankings
In 2016, Jakob Dupont's compensation ranked 9,830th out of 14,075 executives tracked by ExecPay. In other words, Dupont earned more than 30.2% of executives.
| Classification | Ranking | Percentile |
|---|---|---|
All | 9,830 out of 14,075 | 30th |
Division Manufacturing | 3,798 out of 5,489 | 31st |
Major group Chemicals And Allied Products | 1,328 out of 1,895 | 30th |
Industry group Drugs | 1,057 out of 1,538 | 31st |
Industry Pharmaceutical Preparations | 830 out of 1,176 | 29th |
Source: SEC filing on April 13, 2017.
Dupont's colleagues
We found two more compensation records of executives who worked with Jakob Dupont at OncoMed Pharmaceuticals in 2016.